USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 8332.00 | 7360.00 | 3360.00 | - | - | - |
Cost of Revenue | 23.17 Thousand | 80.72 Thousand | - | 252.00 | 163.17 Thousand | 234.14 Thousand |
Gross Profit | -14.83 Thousand | -73.36 Thousand | 3360.00 | -252.00 | -163.17 Thousand | -234.14 Thousand |
Operating Expenses | 8332.00 | 2 Million | 2.64 Million | 1.3 Million | 4.77 Million | 5.17 Million |
Selling, General and Administrative Expenses | 2.09 Million | 1.95 Million | 2.46 Million | 1.29 Million | 3.63 Million | 4.96 Million |
Research and Development Expenses | 114.34 Thousand | 48.85 Thousand | 174.31 Thousand | 13.91 Thousand | 1.13 Million | 208.85 Thousand |
Other Expenses | - | - | 3.06 Million | -545.45 Thousand | -2.16 Million | - |
Cost and Expenses | 2.16 Million | 2.08 Million | 2.71 Million | 1.3 Million | 4.93 Million | 5.4 Million |
Operating Income | -2.15 Million | -2.07 Million | -2.7 Million | -1.3 Million | -4.93 Million | -5.4 Million |
Interest Expense | 37.06 Thousand | 32.4 Thousand | 32.74 Thousand | 30.55 Thousand | 33.18 Thousand | 74.51 Thousand |
Income Tax Expense | - | -147.76 Thousand | -5.00 | -2.00 | 1.00 | 3.00 |
Earnings before Tax | -2.17 Million | -2.09 Million | 321.85 Thousand | -1.66 Million | -7.56 Million | -5.47 Million |
Net Income | -2.17 Million | -2.09 Million | 321.85 Thousand | -1.66 Million | -7.56 Million | -5.47 Million |
Earnings Per Share Basic | -0.01 | -0.01 | 0.00 | -0.02 | -0.08 | -0.09 |
Earnings Per Share Diluted | -0.01 | -0.01 | 0.00 | -0.02 | -0.08 | -0.09 |
Weighted Average Shares Outstanding | 216.42 Million | 183.35 Million | 156.74 Million | 109.15 Million | 93.5 Million | 59.39 Million |
Weighted Average Shares Outstanding (Diluted) | 216.42 Million | 183.35 Million | 156.74 Million | 109.15 Million | 93.5 Million | 59.39 Million |
Gross Margin | -1.78 | -9.97 | 1.00 | - | - | - |
EBIT Margin | -246.32 | -270.78 | -785.63 | - | - | - |
Profit Margin | -260.47 | -285.15 | 95.79 | - | - | - |
EBITDA | -2.05 Million | -1.98 Million | -2.63 Million | -1.28 Million | -4.77 Million | -5.17 Million |
Earnings Before Tax Margin | -258.38 | -281.75 | -806.52 | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 1904.00 | 2389.00 | 1873.00 | 2411.00 | 8332.00 | 1974.00 |
Cost of Revenue | 135.00 | 132.00 | 135.00 | 20.2 Thousand | 80.84 Thousand | 20.21 Thousand |
Gross Profit | 1769.00 | 2257.00 | 1738.00 | -17.79 Thousand | -72.5 Thousand | -18.23 Thousand |
Operating Expenses | 316.74 Thousand | 321.11 Thousand | 450.91 Thousand | 913.68 Thousand | 2.21 Million | 298.09 Thousand |
Selling, General and Administrative Expenses | 316.74 Thousand | 321.11 Thousand | 355.24 Thousand | 935.12 Thousand | - | 298.09 Thousand |
Research and Development Expenses | - | - | 95.67 Thousand | -21.43 Thousand | - | - |
Other Expenses | - | - | - | - | 329.08 Thousand | - |
Cost and Expenses | 316.88 Thousand | 321.24 Thousand | 451.05 Thousand | 933.89 Thousand | 2.29 Million | 318.3 Thousand |
Operating Income | -314.98 Thousand | -318.86 Thousand | -449.18 Thousand | -931.48 Thousand | -2.28 Million | -316.33 Thousand |
Interest Expense | 9843.00 | 18.71 Thousand | 3720.00 | 10.1 Thousand | 37.06 Thousand | 9749.00 |
Income Tax Expense | 5.00 | -2.00 | 5.00 | 1.00 | -1.00 | -2.00 |
Earnings before Tax | -324.97 Thousand | -308.03 Thousand | -452.9 Thousand | -823.2 Thousand | -2.17 Million | -328.4 Thousand |
Net Income | -324.97 Thousand | -308.03 Thousand | -452.9 Thousand | -823.2 Thousand | -2.17 Million | -328.4 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Weighted Average Shares Outstanding | 271.8 Million | 260.97 Million | 255.88 Million | 246.27 Million | 216.42 Million | 221.58 Million |
Weighted Average Shares Outstanding (Diluted) | 271.8 Million | 260.97 Million | 255.88 Million | 246.27 Million | 216.42 Million | 221.58 Million |
Gross Margin | 0.93 | 0.94 | 0.93 | -7.38 | -8.70 | -9.24 |
EBIT Margin | -165.36 | -133.42 | -239.74 | -377.96 | - | -150.01 |
Profit Margin | -170.68 | -128.94 | -241.81 | -341.44 | -260.47 | -166.36 |
EBITDA | -314.84 Thousand | -318.73 Thousand | -449.04 Thousand | -911.27 Thousand | - | -296.12 Thousand |
Earnings Before Tax Margin | -165.43 | -133.47 | -239.82 | -386.35 | -274.29 | -160.25 |
DXYZ
0396
TRU
300056
BAFN
PHARMAID